missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Sitravatinib, MedChemExpress
Description
Sitravatinib (MGCD516) is an orally bioavailable receptor tyrosine kinase (RTK) inhibitor with IC50s of 1.5 nM, 2 nM, 2 nM, 5 nM, 6 nM, 6 nM, 8 nM, 0.5 nM, 29 nM, 5 nM, and 9 nM for Axl, MER, VEGFR3, VEGFR2, VEGFR1, KIT, FLT3, DDR2, DDR1, TRKA, TRKB, respectively. Sitravatinib shows potent single-agent antitumor efficacy and enhances the activity of PD-1 blockade through promoting an antitumor immune microenvironment.
Specifications
Specifications
| Chemical Name or Material | Sitravatinib |
| CAS | 1123837-84-2 |
| Color | Off-White |
| Purity Grade Notes | Research |
| Molecular Formula | C33H29F2N5O4S |
| Quantity | 5 mg |
| Synonym | MGCD516 MG-516 |
| Solubility Information | DMSO : ≥ 32 mg/mL (50.82 mM) |
| SMILES | O=C(C1(C(NC2=CC=C(F)C=C2)=O)CC1)NC3=CC=C(OC4=C5C(C=C(C6=NC=C(CNCCOC)C=C6)S5)=NC=C4)C(F)=C3 |
| Molecular Weight (g/mol) | 629.68 |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?